vitamin D on the course of pneumonia

Evaluation of the effect of vitamin D on the course of pneumonia in patients admitted of Shahid Beheshti Hospital in 2014-2015

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201511023576N3

Enrollment

120

Registered

2017-04-18

Start date

2014-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia. Influenza and pneumonia

Interventions

Intervention 1: The intervention group: start the standard antibiotic treatment for pneumonia and received 1000 units of vitamin D daily for 7 days from the second day after the entry into the study.

Treatment - Drugs

The intervention group: start the standard antibiotic treatment for pneumonia and received 1000 units of vitamin D daily for 7 days from the second day after the entry into the study

Control group: Starting the standard antibiotic treatment for pneumonia and received placebo tablets with the same shape and size from the second day after entry into the study

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: clinical and radiological diagnosis of pneumonia; aged more than 18 years; consent to the entry into the study; able to eat oral vitamin D and placebo. The exclusion criteria: malnutrition; systemic disease; diarrhea; intolerance or sensitivity to vitamin D; recent use of antibiotics.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Clinical signs. Timepoint: At admission, 48 hours after taking the drug, 96 hours after taking the drug, at discharge. Method of measurement: Physical examination.	—

Secondary

Measure	Time frame
Length of stay in hospital. Timepoint: At discharge. Method of measurement: Review patient records.;Hemodynamic. Timepoint: At admission 48 hours after taking the drug, 96 hours after taking the drug, at discharge. Method of measurement: Barometer, thermometer, examination.;Duration of stoping cough and shortness of breath. Timepoint: At admission 48 hours after taking the drug, 96 hours after taking the drug, at discharge. Method of measurement: Question from patient.	—

Measure

Time frame

Length of stay in hospital. Timepoint: At discharge. Method of measurement: Review patient records.;Hemodynamic. Timepoint: At admission 48 hours after taking the drug, 96 hours after taking the drug, at discharge. Method of measurement: Barometer, thermometer, examination.;Duration of stoping cough and shortness of breath. Timepoint: At admission 48 hours after taking the drug, 96 hours after taking the drug, at discharge. Method of measurement: Question from patient.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zahra Soleimani

Kashan University of Medical Sciences

soleimani.zahra@yahoo.com+98 31 5554 0030

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026